Innovation: Today’s patients, tomorrow’s medicines.

August 18, 2020

Sy Pretorius, EVP and Chief Medical & Scientific Officer, Parexel and Gadi Saarony, CEO, Advarra discuss how industry-leading innovations help to reduce the time and cost of development, minimize the burden of taking part in clinical trials for patients, and ultimately increase the likelihood of new treatments being launched. In a changing world, Parexel keeps evolving because the future of clinical trials is now.

Previous Video
Patient registries: Defining the patient
Patient registries: Defining the patient

Parexel’s Leanne Larson, Corporate VP and WW Head, Real-world Evidence speaks with Deborah Collyar, cancer ...

Next Video
Leveraging Real-World Evidence in a Rare Disease Oncology Drug Approval
Leveraging Real-World Evidence in a Rare Disease Oncology Drug Approval

Parexel experts discuss a recent project involving a Rare Disease Oncology therapeutic, in which our expert...